Klára Mezei
University of Debrecen(HU)
Publications by Year
Research Areas
Neutropenia and Cancer Infections, Blood disorders and treatments, Monoclonal and Polyclonal Antibodies Research, Salivary Gland Disorders and Functions, Lung Cancer Research Studies
Most-Cited Works
- → Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer(2012)44 cited
- → A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy‐induced neutropenia in patients with early‐stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study(2020)24 cited
- → An open‐label, dose‐ranging study of Rolontis, a novel long‐acting myeloid growth factor, in breast cancer(2018)11 cited
- → Additive Value of Rheumatoid Factor Isotypes in Sjögren’s Syndrome Patients with Joint Complaints of Different Etiologies—Can Rheumatoid Factor IgA Serve as an Early, Poor Prognostic Biomarker Candidate?(2025)1 cited
- → Obesity: Friend or Foe in Sjögren’s Syndrome Patients?(2024)1 cited
- → Abstract P1-10-05: Randomized phase 2, open-label, dose-ranging study of a novel, long-acting G-CSF (SPI-2012) or pegfilgrastim for the management of neutropenia in patients with breast cancer (BC) treated with (Neo) adjuvant chemotherapy with docetaxel + cyclophosphamide (TC)(2016)
- → Colorectalis májmetastasisok komplex kezelése. Konszenzuskonferencia, Budapest, 2019. április 5.(2019)
- → Abstract P1-13-05: Efficacy and safety of eflapegrastim confirmed in reducing severe neutropenia in breast cancer patients treated with myelosuppressive chemotherapy in the second Phase 3 randomized controlled multinational trial compared to pegfilgrastim (RECOVER trial)(2019)